Cost-utility of the 21-gene recurrence score assay in node-negative and node-positive breast cancer.
Lamond NW; Skedgel C; Rayson D; Lethbridge L; Younis T; Breast Cancer Research And Treatment, 2012, vol. 133, issue 3, p 1115, ISSN 15737217. ISBN 15737217.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef